DiCE gets its 'library' card ready as it speeds development of DNA database-derived molecules with more investor cash

Investors like to see big plans, and Kevin Judice has plenty. The DiCE Molecules CEO is plotting a clinical trial launch for the biotech’s lead …

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

DiCE gets its 'li­brary' card ready as it speeds de­vel­op­ment of DNA data­base-de­rived mol­e­cules with more in­vestor cash